Entity

Pharmalittle

Pharmalittle is a daily newsletter published by STAT that provides brief summaries of the latest news and developments in the pharmaceutical and biotechnology industries.

Why it’s in the news: It is in the news because it consistently aggregates and reports on major, timely stories affecting the sector, such as drug setbacks, legal disputes, and policy changes.

Explore Pharmalittle in the interactive graph

Latest on Pharmalittle

STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more
STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more
STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

Connections

33 entities linked to Pharmalittle across the news graph.

Also connected to (33)

STAT FDA Lilly Argenx We OCC M&A Vaxcyte Medicare Trump IP Beam Novo China Roche Huntington AstraZeneca Regenxbio Medicaid U.S Jazz Pharma Sanofi Replimune Moderna

Open the interactive Neural Web →Intelligence Briefs